Long-term survival and nutritional data in patients with cystic fibrosis treated in a Danish centre
- PMID: 8977604
- PMCID: PMC472653
- DOI: 10.1136/thx.51.10.1023
Long-term survival and nutritional data in patients with cystic fibrosis treated in a Danish centre
Abstract
Background: Adequate nutrition and optimal treatment of bronchopulmonary infections are both of critical importance in maintaining the health of patients with cystic fibrosis. The cystic fibrosis centre in Copenhagen has followed a regimen of very early and aggressive antimicrobial treatment, especially against Pseudomonas aeruginosa infection. An unrestricted diet of low fat and high protein without hyperalimentation was recommended before 1985 which was then changed to a high fat, high calorie intake.
Methods: The overall impact of the treatment regimen was evaluated by a cross sectional analysis of all 223 patients who attended the centre in 1989. Growth and nutritional parameters were combined with lung function parameters and with a retrospective analysis of chronic P aeruginosa infection and its duration. Survival curves for all 313 patients treated at the centre since 1949 were calculated.
Results: All the patients with cystic fibrosis had normal height, although the final height was achieved a little later than in healthy controls. Body weight was lower than normal in males above 15 and in females above 10 years of age. The body mass index (BMI), which was approximately 98% of normal in the younger patients, declined to 90% in adult men and to 83% in adult women with cystic fibrosis, and was strongly correlated with lung function parameters. In 1989 the median age of survival of all patients treated in the centre since 1949 was 30 years (32 years in males and 29 years in females).
Conclusions: The overall treatment regimen in the cystic fibrosis centre in Copenhagen is associated with growth and survival rates that are at least equal to those in other cystic fibrosis centres in other countries.
Similar articles
-
Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project.Thorax. 2002 Jul;57(7):596-601. doi: 10.1136/thorax.57.7.596. Thorax. 2002. PMID: 12096202 Free PMC article.
-
The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.Dev Period Med. 2015 Jan-Mar;19(1):66-79. Dev Period Med. 2015. PMID: 26003072
-
Growth in prepubertal children with cystic fibrosis, homozygous for the Delta F508 mutation.J Cyst Fibros. 2003 Jun;2(2):76-83. doi: 10.1016/S1569-1993(03)00023-7. J Cyst Fibros. 2003. PMID: 15463854
-
[Nutrition, cystic fibrosis and the digestive tract].Nutr Hosp. 2008 May;23 Suppl 2:71-86. Nutr Hosp. 2008. PMID: 18714414 Review. Spanish.
-
Is there a gender gap in cystic fibrosis children?J R Soc Med. 2007;100 Suppl 47:35-7. J R Soc Med. 2007. PMID: 17926727 Review. No abstract available.
Cited by
-
Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis.Eur J Pediatr. 2005 Sep;164(9):577-82. doi: 10.1007/s00431-005-1701-4. Epub 2005 May 31. Eur J Pediatr. 2005. PMID: 15926067
-
Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project.Thorax. 2002 Jul;57(7):596-601. doi: 10.1136/thorax.57.7.596. Thorax. 2002. PMID: 12096202 Free PMC article.
-
Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis.Thorax. 2004 Dec;59(12):1068-73. doi: 10.1136/thx.2004.022590. Thorax. 2004. PMID: 15563707 Free PMC article.
-
Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs.Thorax. 2000 May;55(5):355-8. doi: 10.1136/thorax.55.5.355. Thorax. 2000. PMID: 10770814 Free PMC article. Clinical Trial.
-
Objective and Subjective Sleep Efficiency in Adult Patients with Cystic Fibrosis and Impact on Quality of Life.Lung. 2018 Dec;196(6):761-767. doi: 10.1007/s00408-018-0167-x. Epub 2018 Oct 3. Lung. 2018. PMID: 30284025